Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.
2.

A doxorubicin-CNGRC-peptide conjugate with prodrug properties.

van Hensbergen Y, Broxterman HJ, Elderkamp YW, Lankelma J, Beers JC, Heijn M, Boven E, Hoekman K, Pinedo HM.

Biochem Pharmacol. 2002 Mar 1;63(5):897-908.

PMID:
11911842
3.

Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions.

Lee CG, Heijn M, di Tomaso E, Griffon-Etienne G, Ancukiewicz M, Koike C, Park KR, Ferrara N, Jain RK, Suit HD, Boucher Y.

Cancer Res. 2000 Oct 1;60(19):5565-70.

4.

Specific detection of multidrug resistance proteins MRP1, MRP2, MRP3, MRP5, and MDR3 P-glycoprotein with a panel of monoclonal antibodies.

Scheffer GL, Kool M, Heijn M, de Haas M, Pijnenborg AC, Wijnholds J, van Helvoort A, de Jong MC, Hooijberg JH, Mol CA, van der Linden M, de Vree JM, van der Valk P, Elferink RP, Borst P, Scheper RJ.

Cancer Res. 2000 Sep 15;60(18):5269-77.

5.

Potent interaction of flavopiridol with MRP1.

Hooijberg JH, Broxterman HJ, Scheffer GL, Vrasdonk C, Heijn M, de Jong MC, Scheper RJ, Lankelma J, Pinedo HM.

Br J Cancer. 1999 Sep;81(2):269-76.

6.
7.

Canalicular multispecific organic anion transporter/multidrug resistance protein 2 mediates low-affinity transport of reduced glutathione.

Paulusma CC, van Geer MA, Evers R, Heijn M, Ottenhoff R, Borst P, Oude Elferink RP.

Biochem J. 1999 Mar 1;338 ( Pt 2):393-401.

8.

A method for studying plasma membrane transport with intact cells using computerized fluorometry.

Wielinga PR, Heijn M, Westerhoff HV, Lankelma J.

Anal Biochem. 1998 Oct 15;263(2):221-31.

PMID:
9799535
9.

P-glycoprotein-independent decrease in drug accumulation by phorbol ester treatment of tumor cells.

Wielinga PR, Heijn M, Broxterman HJ, Lankelma J.

Biochem Pharmacol. 1997 Oct 1;54(7):791-9.

PMID:
9353133
10.

Modulation by (iso)flavonoids of the ATPase activity of the multidrug resistance protein.

Hooijberg JH, Broxterman HJ, Heijn M, Fles DL, Lankelma J, Pinedo HM.

FEBS Lett. 1997 Aug 18;413(2):344-8.

11.

Anthracyclines modulate multidrug resistance protein (MRP) mediated organic anion transport.

Heijn M, Hooijberg JH, Scheffer GL, Szabó G, Westerhoff HV, Lankelma J.

Biochim Biophys Acta. 1997 May 22;1326(1):12-22.

12.

Re: How does the MRP/GS-X pump export doxorubicin?

Broxterman HJ, Heijn M, Lankelma J.

J Natl Cancer Inst. 1996 Apr 3;88(7):466-8. No abstract available.

PMID:
8618244
13.

Redistribution of canalicular organic anion transport activity in isolated and cultured rat hepatocytes.

Roelofsen H, Bakker CT, Schoemaker B, Heijn M, Jansen PL, Elferink RP.

Hepatology. 1995 Jun;21(6):1649-57.

PMID:
7768511
14.

Accumulation of organic anion in intracellular vesicles of cultured rat hepatocytes is mediated by the canalicular multispecific organic anion transporter.

Oude Elferink RP, Bakker CT, Roelofsen H, Middelkoop E, Ottenhoff R, Heijn M, Jansen PL.

Hepatology. 1993 Mar;17(3):434-44.

PMID:
8444418
15.

ATP-dependent multispecific organic anion transport system in rat erythrocyte membrane vesicles.

Heijn M, Oude Elferink RP, Jansen PL.

Am J Physiol. 1992 Jan;262(1 Pt 1):C104-10.

PMID:
1531100
16.

Effect of substituted benzoates on p-aminohippurate transport in dog renal membrane vesicles.

Russel FG, Heijn M, de Laet RC, van Ginneken CA.

Naunyn Schmiedebergs Arch Pharmacol. 1991 Jan;343(1):102-7.

PMID:
2030743
17.

Na+ and H+ gradient-dependent transport of p-aminohippurate in membrane vesicles from dog kidney cortex.

Russel FG, van der Linden PE, Vermeulen WG, Heijn M, van Os CH, van Ginneken CA.

Biochem Pharmacol. 1988 Jul 1;37(13):2639-49.

PMID:
3390224

Supplemental Content

Support Center